
Following the announced end of production of the active ingredient metamizole – better known by the trade name Novalgin – in Germany and Europe, the health policy spokesperson for the CDU/CSU parliamentary group in the German Bundestag, Tino Sorge, has expressed alarm. "Contrary to all announcements by Minister Lauterbach, another pharmaceutical active ingredient is disappearing from domestic production," Sorge told the newspapers of the Funke Media Group. [...]
Union alarmed about end of metamizole production in Europe
